Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-19-011907
Filing Date
2019-03-18
Accepted
2019-03-18 17:36:30
Documents
2
Period of Report
2019-03-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 5653
2 POWER OF ATTORNEY (PUBLIC): POWER OF ATTORNEY doc1.txt EX-24 3900
  Complete submission text file 0001127602-19-011907.txt   10934
Mailing Address 1100 PARK PLACE SUITE 300 SAN MATEO CA 94403
Business Address
Crane Rosemary A (Reporting) CIK: 0001443343 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37568 | Film No.: 19689474

Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Issuer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations